Integration of IP and Regulatory Exclusivity Strategies for Emerging Life Science Companies
Raymond A. Miller and N. Nicole Endejann, Pittsburgh attorneys in Pepper Hamilton’s Intellectual Property Practice and Life Sciences Practice, and Tom Petzinger, Executive Vice President of Business Development and Public Affairs of Knopp Neurosciences Inc., identify the intellectual property and regulatory exclusivity strategies necessary for emerging life science companies to secure investments, strategic partnerships or licenses with third parties. In addition to reviewing critical IP strategies, this podcast discusses the recent Knopp – Biogen Idec transaction, in which Pepper served as IP counsel. Knopp developed the drug, dexpramipexole, for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and potentially other indications. In August, Biogen Idec and Knopp Neurosciences entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize the drug.
Email email@example.com to subscribe to Pepper Hamilton’s IP Alerts and Updates.
(Running Time: 26:28)
False Marking and Private Enforcement After Forest Group v. Bon Tool
On March 17, 2010, Josh Slavitt, a registered patent attorney and a partner in the Philadelphia office of Pepper Hamilton who practices in all areas of intellectual property law, will be speaking on a teleconference and live audio webcast for the American Bar Association Center for Continuing Legal Education entitled “False Marking and Private Enforcement After Forest Group v. Bon Tool.”
In this podcast, Josh discusses the recent flood of false marking lawsuits being filed and what companies should do to minimize their potential liability.
For more information and to register for the March 17, 2010 teleconference, visit www.abanet.org.
(Running Time: 4:52)
Internal Battle Over Trademarks in Today’s Business Climate
In this podcast, Mike Rule, partner in Pepper’s Orange County office with particular experience in the representation of clients’ trademark portfolios, discusses the internal battle that a company’s marketing and legal departments sometime go through over trademarks in today’s business climate. Mike has maintained and protected more than 1,000 marks in more than 100 jurisdictions.
Email firstname.lastname@example.org to subscribe to Pepper Hamilton’s Corporate and Securities Law Update to receive regular updates on these types of topics.
(Running Time: 11:18)